Penumbra (PEN) EBT Growth (1y) (2015 - 2026)
Penumbra (PEN) EBT Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -29.12% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 53.94% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 12.65% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 29.89% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 31.69% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 13.05% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 71.38% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 17.94% |
| 10 | Penumbra | 12.79 Bn | 12.13 Bn | 264.94 Mn | 1.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94% |
| Mar 31, 2026 | -4.95% |
| Dec 31, 2025 | 43.51% |
| Sep 30, 2025 | 31.54% |
| Jun 30, 2025 | 158.18% |
| Mar 31, 2025 | 199.86% |
| Dec 31, 2024 | 16.20% |
| Sep 30, 2024 | 198.99% |
| Jun 30, 2024 | -498.62% |
| Mar 31, 2024 | 69.05% |
| Dec 31, 2023 | 435.33% |
| Sep 30, 2023 | 338.35% |
| Jun 30, 2023 | 1,774.04% |
| Mar 31, 2023 | 269.51% |
| Dec 31, 2022 | 117.40% |
| Sep 30, 2022 | -61.00% |
| Jun 30, 2022 | -111.44% |
| Mar 31, 2022 | -140.94% |
| Dec 31, 2021 | -7,914.48% |
| Sep 30, 2021 | 139.44% |